Editor - Kunio Yui | Tokyo University | 23797
ISSN: 2375-4494

Journal of Child and Adolescent Behavior
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Kunio Yui

Kunio Yui
Editor-In-Chief Kunio Yui
Department of Cognitive-Behavioral Medicine
Tokyo University Graduate School of Medicine
Tokyo University


Dr. Kunio Yui is now visiting researcher, Department of Cognitive-Behavioral Medicine, Tokyo University Graduate School of Medicine , where he has been since October, 2016. He was a sometime Professor of the Research Institute of Developmental Disorders at Ashiya University Graduate Sdchool of Education, where he has been since 2006. He graduated From Juntendo University , Fasculty of Medicine (Tokyo, Japan). He received a PhD. from the University of Hirosaki in 1988. From 1989 to 2005 he worked and reseached in the field of neurosciences in mental disorderes and developmental disorders in the Depatment of Pdychiatry, Jichi Medical School (Tochigi, Japan) as an assistant (1989-1995) and associate professor (1995-2005).

Research Interest

My research interests span both bilogical psychiatry andneuroscience. I published many english papers on five topics; 1) clomiphene treatment in bipolar depression related to menstration in female adolescents: 2) the role of noreadrenergic hyperactivity in spintaneous ecurrence of meth mphetasmine psychosis; 3) stress maeker in molar as predisposition of development of schizophrenia; 4) therapeutic effects of arachidonic acid suntherapeutic potential of antitumor drug everolimus in improving autism pplementation in autism and 5) therapeutic potential of antitumordrug everolimus in autism symptoms in tuberous screlosis. These dfindings are completely new and important in the medical treatmentn of mental disorders. I was given numerous invited talks and tutorials, and is a founder of and consultant to companies involved in Neuropsychopharmacology


The Large Effect Size of Urinary Total Antioxidant Capacity in Behavioral Symptoms of Young Autistic Individuals: Comparion with Omega-3 Fatty Acid and Superoxide Dismutase in Plasma

Psychological Discrepancies found in Children and Adolescents

Kunio Yui, Hitomi Sasaki, Nasoyuki Tanuma and Yohei Kawasaki
Research Article: J Child Adolesc Behav 2018, 6: 367
DOI: 10.4172/2375-4494.1000367

Therapeutic Potential of Everolimus on Core Autism Symptoms andIncreasing Serum Ceruloplasmin and Transferrin Levels in a PubescentBoy with Tuberous Sclerosis

Kunio Yui
Editor Note: J Child Adolesc Behav 2017, 5: e118
DOI: 10.4172/2375-4494.1000e118

Efficacy of Adding Large Doses of Arachidonic Acid to Docosahexaenoic Acid against Restricted Repetitive Behaviors in Individuals with AutismSpectrum Disorders: A Placebo-Controlled Trial

Kunio Yui, George Imataka, Toru Okanishi, Hidehiro Oka and Yohei Kawasaki
Case Report: Neonat Pediatr Med 2017, 3:128
DOI: 10.4172/2572-4983.1000128
Kunio Yui, Mamiko Koshiba, Shun Nakamura, Yuji Kobayashim and Masaki Ohnishi
Research Article: J Addict Res Ther 2011, S4
DOI: 10.4172/2155-6105.S4-006